• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Cannabinoid Biotech Stocks Up Big Intraday

April 10, 2017

 

We're now halfway through Monday's trading session here in New York, and there's a handful of cannabinoid biotech and pharmaceutical names on my radar. These stocks have been very active recently, with many reporting positive news regarding research and development. 

 

The NASDAQ Biotechnology Index is down roughly 0.25% so far, but cannabinoid biotech is up big!

 

 

 

Cara Therapeutics Inc.

 

Cara Therapeutics (NASDAQ:CARA) is up roughly 3% in intraday trading on no recent news and average trading volume. In early morning trading, shares of CARA got up as high as $19.08 per share on bursts of buying action, but is pacing its gains. We'll be watching how the rest of the day plays out for CARA.

 

Insys Therapeutics Inc. 

 

Insys Therapeutics (NASDAQ:INSY) is up roughly 4.92% in intraday trading on no recent news and average trading volume. In early morning trading, shares of INSY got up to highs of $11.10 per share, but are trading lower now on weak volume. INSY holds a roughly 9.5% weighting in the recently launched marijuana ETF. We'll be watching how the rest of the trading day finishes up for INSY. 

 

Therapix Biosciences Ltd.

 

Therapix Biosciences (NASDAQ:TRPX) is up roughly 6.18% in intraday trading despite it's shares in Tel Aviv closing down 2.29% on below average volume. Last Tuesday, Therapix announced that their underwriters exercised their over-allotment options, signaling bullish opinions on Wall Street regarding the recently listed stock. We'll be watching how the rest of the session finishes up for TRPX. 

 

Zynerba Pharmaceuticals Inc. 

 

Zynerba Pharmaceuticals (NASDAQ:ZYNE) is up roughly 9.64% in intraday trading, leading the pack for cannabinoid pharma and biotech today. Zynerba holds a roughly 7.5% weighting in the recently launched medical marijuana ETF that just began trading last week. We'll be watching to see how strong the market is for ZYNE up at 52-Week highs. 

 

D/M/O

 

Did you know trading these stocks commission-free is easy with a Robinhood account?

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.